Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee

Nancy E Lane1

  • 1Division of Rheumatology and Clinical Immunology, U.C. Davis Health, Sacramento, CA. 94143, USA.

Insights

Targeting the Wnt signaling pathway shows promise for treating painful osteoarthritis (OA). Clinical studies suggest earlier intervention and longer treatment durations may improve outcomes for knee OA patients.

Area of Science:

  • Orthopedics
  • Pharmacology
  • Molecular Biology

Background:

  • Osteoarthritis (OA) is a significant cause of knee pain and disability.
  • The Wnt signaling pathway is implicated in OA pathogenesis.
  • Preclinical and epidemiological data support targeting Wnt signaling for OA treatment.

Purpose of the Study:

  • To review clinical studies on Wnt signaling modulators for knee OA.
  • To provide recommendations for future OA treatment strategies.

Main Methods:

  • Literature review of clinical trials involving Wnt pathway agents for knee OA.
  • Analysis of study designs, treatment durations, and patient outcomes.

Main Results:

  • Evidence suggests Wnt pathway modulation is a viable therapeutic approach for knee OA.
  • Current clinical studies may be limited by late-stage disease intervention and short treatment durations.

Conclusions:

  • Wnt signaling modulation holds potential for managing painful knee OA.
  • Future research should focus on earlier disease intervention and extended treatment periods for optimal efficacy.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K